Digitale, Erin
May 2013
Stanford Medicine;Spring2013, Vol. 30 Issue 1, p42
The article focuses on the Isabella Messina, the daughter of Kim McFall and Giovanni Messina who was diagnosed with a rare of severe combined immunodeficiency (SCID) at the age of three weeks. It says that the treatment for the SCID was started by the physicians of Isabella by using immune-suppressing drugs to bring her rogue T cells under control. It adds that the test results of Isabella has jumped before the schedule of the third stem cell transplant in October 2011.


Related Articles

  • The Case for Mandatory Newborn Screening for Severe Combined Immunodeficiency (SCID). Gaspar, H.; Hammarström, L.; Mahlaoui, N.; Borte, M.; Borte, S. // Journal of Clinical Immunology;May2014, Vol. 34 Issue 4, p393 

    Severe combined immunodeficiency (SCID) is the most severe form of inherited primary immunodeficiency and is a paediatric emergency. Delay in recognising and detecting SCID can have fatal consequences and also reduces the chances of a successful haematopoietic stem cell transplant (HSCT)....

  • Newborn Screening for Severe Combined Immunodeficiency; The Wisconsin Experience (2008-2011). Verbsky, James; Baker, Mei; Grossman, William; Hintermeyer, Mary; Dasu, Trivikram; Bonacci, Benedetta; Reddy, Sreelatha; Margolis, David; Casper, James; Gries, Miranda; DeSantes, Ken; Hoffman, Gary; Brokopp, Charles; Seroogy, Christine; Routes, John // Journal of Clinical Immunology;Feb2012, Vol. 32 Issue 1, p82 

    Severe combined immunodeficiency is a life-threatening primary immune deficiency characterized by low numbers of naïve T cells. Early diagnosis and treatment of this disease decreases mortality. In 2008, Wisconsin began newborn screening of infants for severe combined immunodeficiency and...

  • Severe combined immunodeficiency: recent developments and guidance on clinical management. Rivers, Lizzy; Gaspar, H. Bobby // Archives of Disease in Childhood;Jul2015, Vol. 100 Issue 7, p667 

    Severe combined immunodeficiency (SCID) is a rare but important condition. Affected infants are born with profound abnormalities of immune cell function that lead to severe and recurrent infection that are almost always fatal in the first year of life without treatment. Infants with SCID are...

  • Severe Combined Immunodeficiency (SCID) in Canadian Children: A National Surveillance Study. Rozmus, Jacob; Junker, Anne; Thibodeau, Melanie Laffin; Grenier, Danielle; Turvey, Stuart E.; Yacoub, Wadieh; Embree, Joanne; Haddad, Elie; Langley, Joanne M.; Ramsingh, Rose Marie; Singh, Veeran-Anne; Long, Richard; Schultz, Kirk R. // Journal of Clinical Immunology;Nov2013, Vol. 33 Issue 8, p1310 

    Purpose: Severe Combined Immune Deficiency (SCID) is universally fatal unless treated with hematopoietic stem cell transplantation (HSCT). Following the identification of disseminated Bacille Calmette-Guérin (BCG) infections in Canadian First Nations, Métis and Inuit (FNMI) children with...

  • Noninvasive Optical Imaging and In Vivo Cell Tracking of Indocyanine Green Labeled Human Stem Cells Transplanted at Superficial or In-Depth Tissue of SCID Mice. Sabapathy, Vikram; Mentam, Jyothsna; Jacob, Paul Mazhuvanchary; Kumar, Sanjay // Stem Cells International;7/9/2015, Vol. 2015, p1 

    Stem cell based therapies hold great promise for the treatment of human diseases; however results from several recent clinical studies have not shown a level of efficacy required for their use as a first-line therapy, because more often in these studies fate of the transplanted cells is unknown....

  • Severe combined immunodeficiency in the newborn. Maggina, Paraskevi; Gennery, Andrew R. // Infant;Mar2013, Vol. 9 Issue 2, p52 

    Severe combined immunodeficiencies (SCIDs) are a group of rare diseases of T-lymphocyte or thymic failure, which comprise the most severe immunodeficiencies. Generally fatal by one year of age without treatment, they constitute a paediatric emergency and early diagnosis facilitates a better...

  • Newborn Screening for SCID in New York State: Experience from the First Two Years. Vogel, Beth; Bonagura, Vincent; Weinberg, Geoffrey; Ballow, Mark; Isabelle, Jason; DiAntonio, Lisa; Parker, April; Young, Allison; Cunningham-Rundles, Charlotte; Fong, Chin-To; Celestin, Jocelyn; Lehman, Heather; Rubinstein, Arye; Siegel, Subhadra; Weiner, Leonard; Saavedra-Matiz, Carlos; Kay, Denise; Caggana, Michele // Journal of Clinical Immunology;Apr2014, Vol. 34 Issue 3, p289 

    Purpose: To describe the process and assess outcomes for the first 2 years of newborn screening for severe combined immunodeficiency (SCID NBS) in New York State (NYS). Methods: The NYS algorithm utilizes a first-tier molecular screen for TRECs (T-cell receptor excision circles), the absence of...

  • Expert Commentary: Practical Issues in Newborn Screening for Severe Combined Immune Deficiency (SCID). Puck, Jennifer; Routes, Jack; Filipovich, Alexandra; Sullivan, Kate // Journal of Clinical Immunology;Feb2012, Vol. 32 Issue 1, p36 

    No abstract available.

  • CORRECTION.  // JAMA: Journal of the American Medical Association;9/24/2014, Vol. 312 Issue 12, p1259 

    A correction is presented to the article "Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States," published in the August 20, 2014 issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics